Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Randall J. Yetman, MD, is Head of the Section of Breast Surgery in the Department of Plastic and Reconstructive Surgery at Cleveland Clinic. After receiving his degree from the University of Miami School of Medicine, Dr. Yetman completed his internship and residency in general surgery at Montefiore Hospital and Medical Center in Bronx, New York. He completed a residency in plastic surgery at New York Hospital/Cornell Medical Center in New York City. He also completed a hand surgery fellowship at Cleveland Clinic. His special interests include breast reconstruction, breast surgery and cosmetic surgery. His clinical interests include microvascular surgery, breast surgery, melanoma and breast reconstruction.
In April 2002, Dr. Yetman was named one of the nation's Best Doctors for Women in Ladies' Home Journal magazine. Board-certified in plastic surgery, Dr. Yetman is a member of numerous professional societies including the American Society for Reconstructive Microsurgery, the American Board of Plastic and Reconstructive Surgeons and the American College of Surgeons.
A frequent lecturer at national and international meetings, he has authored more than 50 major journal articles, book chapters and textbooks. Currently, Dr. Yetman is involved in the clinical investigation of outcomes of breast reconstruction (TRAM) following mastectomy for breast cancer.
Breast Reconstruction, breast surgery, Cosmetic Surgery, Melanoma, Microvascular Surgery
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/20/2012, Dr. Yetman has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.